Reprogrammed Interchange LLC - 01 Oct 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
10%+ Owner
Signature
/s/ Reid Hoffman
Issuer symbol
VOR
Transactions as of
01 Oct 2025
Net transactions value
-$1,646,237
Form type
4
Filing time
03 Oct 2025, 21:12:18 UTC
Previous filing
18 Sep 2025
Next filing
08 Oct 2025

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Reprogrammed Interchange LLC 10%+ Owner 101 MISSION STREET, SUITE 1000, SAN FRANCISCO /s/ Reid Hoffman 03 Oct 2025 0002050755
Hoffman Reid 10%+ Owner 101 MISSION STREET, SUITE 1000, SAN FRANCISCO /s/ Frank Huang, Manager of Reprogrammed Interchange LLC 03 Oct 2025 0001519339

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Sale $54,870 -1,400 -0.09% $39.19 1,637,660 01 Oct 2025 Direct F1, F2, F3
transaction VOR Common Stock Sale $183,685 -4,937 -0.3% $37.21 1,632,723 02 Oct 2025 Direct F3, F4
transaction VOR Common Stock Sale $58,065 -1,513 -0.09% $38.38 1,631,210 02 Oct 2025 Direct F3, F5
transaction VOR Common Stock Sale $304,711 -7,700 -0.47% $39.57 1,623,510 02 Oct 2025 Direct F3, F6
transaction VOR Common Stock Sale $521,707 -13,001 -0.8% $40.13 1,610,509 02 Oct 2025 Direct F3, F7
transaction VOR Common Stock Sale $224,291 -5,300 -0.33% $42.32 1,605,209 02 Oct 2025 Direct F3, F8
transaction VOR Common Stock Sale $119,594 -3,200 -0.2% $37.37 1,602,009 03 Oct 2025 Direct F3, F9
transaction VOR Common Stock Sale $179,317 -4,701 -0.29% $38.14 1,597,308 03 Oct 2025 Direct F3, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $39.11 to $39.415. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F2 The number of shares beneficially owned reflects the 1-for-20 reverse stock split effected September 18, 2025.
F3 The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.
F4 This transaction was executed in multiple trades at prices ranging from $36.82 to $37.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $37.85 to $38.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $39.20 to $39.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $39.86 to $40.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $42.00 to $42.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 This transaction was executed in multiple trades at prices ranging from $36.88 to $37.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10 This transaction was executed in multiple trades at prices ranging from $38.00 to $38.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.